SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001493152-25-006746 from Basel Medical Group Ltd (BMGL)

Basel Medical Group Ltd
Date: Feb. 14, 2025 · CIK: 0002004489 · Accession: 0001493152-25-006746

AI Filing Summary & Sentiment

File numbers found in text: 333-282096

Date
Feb. 14, 2025
Author
Director
Form
CORRESP
Company
Basel Medical Group Ltd

Letter

Basel Medical Group Ltd

Napier Road,

Unit #02-10/11 Gleneagles Medical Centre

Singapore

February 14, 2025

Via EDGAR

Division of Corporation Finance

Office of Industrial Application & Services

U.S. Securities and Exchange Commission

F Street, NE

Washington, D.C., 20549

Attention: Nudrat Salik

Michael Fay

Robert Augustin

Jane Park

Re: Basel Medical Group Ltd

Registration Statement on Form F-1, as amended (File No. 333-282096)

Request for Acceleration of Effectiveness

Ladies and Gentlemen:

In accordance with Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Basel Medical Group Ltd hereby requests that the effectiveness of the above-referenced Registration Statement on Form F-1 (the “Registration Statement”) be accelerated and that the Registration Statement become effective at 4:00 p.m., Eastern Time, on February 18, 2025, or as soon thereafter as practicable.

Very
truly yours,
Basel
Medical Group Ltd

Show Raw Text
CORRESP
1
filename1.htm

Basel
Medical Group Ltd

6
Napier Road,

Unit
#02-10/11 Gleneagles Medical Centre

Singapore
258499

February
14, 2025

Via
EDGAR

Division
of Corporation Finance

Office
of Industrial Application & Services

U.S.
Securities and Exchange Commission

100
F Street, NE

Washington,
D.C., 20549

    Attention:
    Nudrat
    Salik

    Michael
    Fay

    Robert
    Augustin

    Jane
    Park

    Re:
    Basel
    Medical Group Ltd

    Registration
    Statement on Form F-1, as amended (File No. 333-282096)

    Request
    for Acceleration of Effectiveness

Ladies
and Gentlemen:

In
accordance with Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Basel Medical Group Ltd hereby
requests that the effectiveness of the above-referenced Registration Statement on Form F-1 (the “Registration Statement”)
be accelerated and that the Registration Statement become effective at 4:00 p.m., Eastern Time, on February 18, 2025,
or as soon thereafter as practicable.

    Very
    truly yours,

    Basel
    Medical Group Ltd

    By:
    /s/
    Raymond Wai Man Cheung

    Name:
    Raymond
Wai Man Cheung

    Title:
    Director
and Chief Executive Officer

    cc:
    Benjamin
                                            Tan, Esq.

    Martryn
    Mak, Esq.

    Sichenzia
    Ross Ference Carmel LLP